AstraZeneca
AZNH
AZNH was delisted on the 29th of January, 2026.
1 hedge funds and large institutions have $2.09M invested in AstraZeneca in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
43% less capital invested
Capital invested by funds: $3.63M → $2.09M (-$1.55M)
62.41% less ownership
Funds ownership: 113.32% → 50.91% (-62%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$1.2M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $2.09M | -$1.2M | -28,411 | -36% |
|
AZNH Hedge Fund Activity: Q2 2025 in Review
1 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZNH) for Q2 2025, worth a combined $2.09M — down 43% from $3.63M a quarter earlier.
Fund positioning in AZNH was balanced in Q2 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Citadel Advisors, cutting an estimated $1.2M.
- 1 institutional investor held AstraZeneca (AZNH) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $2.09M of AstraZeneca stock for Q2 2025, down 43% quarter-over-quarter.
- 0 funds opened new AstraZeneca positions in Q2 2025 and 0 closed out.
- The largest AstraZeneca seller in Q2 2025 was Citadel Advisors, an estimated $1.2M sold.
Based on aggregated 13F filings for Q2 2025.